Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge
AuthorsRiley, Margaret A.
Robinson, Sandra M.
Roy, Christopher M.
Dorit, Robert L.
Document TypeJournal Article
Drug Resistance, Bacterial
Escherichia coli Infections
Microbial Sensitivity Tests
Amino Acids, Peptides, and Proteins
Biochemistry, Biophysics, and Structural Biology
MetadataShow full item record
AbstractPathogenic bacteria resistant to many or all antibiotics already exist. With the decline in microbiological research at pharmaceutical companies, the high rate at which resistance has evolved and spread has demanded a novel approach to addressing this critical human health issue. In the present paper, we propose a new paradigm in antibiotic discovery and development, one that applies ecological and evolutionary theory to design antimicrobial drugs that are more difficult and/or more costly to resist. In essence, we propose to simply adopt the strategies invented and applied by bacteria for hundreds of millions of years. Our research focuses on bacteriocins, powerful biological weapons, and their use as alternative therapeutics in human health.
SourceBiochem Soc Trans. 2012 Dec 1;40(6):1438-42. doi: 10.1042/BST20120179.
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/50302
Related ResourcesLink to article in PubMed